Ventricular arrhythmias: current concepts.
These conventional antiarrhythmic agents, plus tocainide, are important drugs for the treatment of ventricular arrhythmias. It is necessary to be familiar with their mechanism of action, pharmacokinetics, dosage, and adverse effects to properly use them in the treatment of ventricular arrhythmias.
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D016677:Tocainide
D000889:Anti-Arrhythmia Agents; D016677:Tocainide; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide